Chronic stress accelerates glioblastoma progression via DRD2/ERK/β-catenin axis and Dopamine/ERK/TH positive feedback loop
Open Access
- 7 July 2023
- journal article
- research article
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 42 (1) , 1-17
Abstract
Background: After diagnosis, glioblastoma (GBM) patients undertake tremendous psychological problems such as anxiety and depression, which may contribute to GBM progression. However, systematic study about the relationship between depression and GBM progression is still lacking. Methods: Chronic unpredictable mild stress and chronic restrain stress were used to mimic human depression in mice. Human GBM cells and intracranial GBM model were used to assess the effects of chronic stress on GBM growth. Targeted neurotransmitter sequencing, RNA-seq, immunoblotting and immunohistochemistry were used to detect the related molecular mechanism. Results: Chronic stress promoted GBM progression and up-regulated the level of dopamine (DA) and its receptor type 2 (DRD2) in tumor tissues. Down-regulation or inhibition of DRD2 abolished the promoting effect of chronic stress on GBM progression. Mechanistically, the elevated DA and DRD2 activated ERK1/2 and consequently inhibited GSK3β activity, leading to β-catenin activation. Meanwhile, the activated ERK1/2 up-regulated tyrosine hydroxylase (TH) level in GBM cells and then promoted DA secretion, forming an autocrine positive feedback loop. Remarkably, patients with high-depression exhibited high DRD2 and β-catenin levels, which showed poor prognosis. Additionally, DRD2 specific inhibitor pimozide combined with temozolomide synergistically inhibited GBM growth. Conclusions: Our study revealed that chronic stress accelerates GBM progression via DRD2/ERK/β-catenin axis and Dopamine/ERK/TH positive feedback loop. DRD2 together with β-catenin may serve as a potential predictive biomarker for worse prognosis as well as therapeutic target of GBM patients with depression.Keywords
Funding Information
- National Natural Science Foundation of China (82273111, 82072770, 81902526)
This publication has 37 references indexed in Scilit:
- Low concentration trifluoperazine promotes proliferation and reduces calcium-dependent apoptosis in glioma cellsScientific Reports, 2018
- β-catenin-mediated YAP signaling promotes human glioma growthJournal of Experimental & Clinical Cancer Research, 2017
- Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cellsJournal of Molecular Cell Biology, 2017
- Depression in cancer: The many biobehavioral pathways driving tumor progressionCancer Treatment Reviews, 2017
- Antidepressant drugs can modify cytotoxic action of temozolomideEuropean Journal of Cancer Care, 2016
- A protocol for the Hamilton Rating Scale for Depression: Item scoring rules, Rater training, and outcome accuracy with data on its application in a clinical trialJournal of Affective Disorders, 2016
- A Cognitive–Emotional Biomarker for Predicting Remission with Antidepressant Medications: A Report from the iSPOT-D TrialNeuropsychopharmacology, 2014
- Frequency, Clinical Associations, and Longitudinal Course of Major Depressive Disorder in Adults With Cerebral GliomaJournal of Clinical Oncology, 2011
- Dopamine Blocks Stress-Mediated Ovarian Carcinoma GrowthClinical Cancer Research, 2011
- Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinomaNature Medicine, 2006